European Medicines Agency is an important partner in generating real world evidence.

Europe’s lead regulatory authority is very active in working with real work data (RWD) in its pursuit of its statutory goals of: Facilitate development and access to medicines Evaluate applications for marketing authorisation Monitor the safety of medicines across the life cycle Provide reliable information to patients and the public EMA is working towards and … Read more

Launch of the EHDEN Service Provider Directory

At the end of 2019, EHDEN launched the EHDEN ‘Directory of Service Providers’. EHDEN’s main objective is to create an EU-wide eco-system for federated analyses of real world data standardised to the OMOP CDM. By listing all EHDEN certified SMEs in this directory, we enable data partners to easily find the SME of their choice … Read more

Results of the first EHDEN open call for data partners

The EHDEN consortium is pleased to announce that a total of 20 data partners have been selected in the first open call for data partners. Having received a total of 29 eligible applications, these 20 applications were selected by the EHDEN Data Source Prioritisation Committee. Combined, the 20 selected data partners represent over 150 million … Read more

IMI/BD4BO Collaboration at BioDataWorld 2019

On 4-5 December, one of the year’s major real-world data events took place again in Basel, Switzerland: BioDataWorld 2019. Among the almost 2,000 attendees coming from 28 countries, the IMI’s (Innovative Medicines Initiative) BD4BO (Big Data For Better Outcomes) project teams (EHDEN, HARMONY, BigData@Heart, PIONEER and ROADMAP) collaborated to raise awareness about their work and … Read more